MEGAN FISHER: Open Payments
NPI 1548849144 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,829 in 158 payments from 37 companies in 2025. Trend: 2023 $943 · 2024 $1,850 · 2025 $2,829
Food & beverage: $2,621Education: $208
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $392 |
| PFIZER INC. | 14 | $237 |
| ABBVIE INC. | 12 | $225 |
| AstraZeneca Pharmaceuticals LP | 8 | $208 |
| Daiichi Sankyo Inc. | 11 | $187 |
| Astellas Pharma US Inc | 10 | $149 |
| Merck Sharp & Dohme LLC | 10 | $148 |
| Incyte Corporation | 4 | $142 |
| E.R. Squibb & Sons, L.L.C. | 6 | $126 |
| Celgene Corporation | 5 | $98 |
Products named: KISQALI, VENCLEXTA, Xtandi, KEYTRUDA, ENHERTU, REBLOZYL, IBRANCE, PLUVICTO.
Industry payments across KY — which companies pay providers there.
